Navigation Links
LUCA technologies confirms real-time methane generation

Luca Technologies LLC today announced that its researchers have confirmed the presence of a resident, methane-generating community of microorganisms ("microbial consortium") in substrate samples taken from the 110,000 acre Monument Butte oilfield located in North Eastern Utah. This site represents the latest in a series of active "GeobioreactorsTM" that Luca Technologies has identified since its first demonstration of this phenomenon in the Powder River Basin coalfields of Wyoming.

Geobioreactors are sites where microbial conversion of underground hydrocarbon deposits (oil, oil shales, and coal) to methane is ongoing. Such Geobioreactors may offer the potential of turning currently finite energy reserves into methane "farms" capable of long-term, sustainable energy generation.

"The hydrocarbon resources available in the Monument Butte oilfield are very large, making the possibility of shifting from oil production to the ongoing farming of clean, natural gas an attractive consideration," said Robert Pfeiffer, president and chief executive officer of Luca Technologies. He noted that the Monument Butte site was one of six oil fields across the United States that Luca has been studying. The company has demonstrated two of those sites to be robust, methane-generating Geobioreactors, and two to be less actively generating methane. Three additional sites are not currently active but may have the potential to be turned into active Geobioreactors through cross-inoculation with microbial consortia from active sites.

Luca scientists have also begun to isolate and identify particular members of the Monument Butte microbial consortium. Through partial DNA sequence analysis, the company has identified Clostridia and Thermatoga as two of the key members of this consortium. Clostridia form a broad genus of bacteria known for their diverse metabolic pathways. Clostridia frequently thrive in anaerobic environments and many species are known for their heat toler
'"/>

Source:LUCA Technologies


Page: 1 2 3

Related biology news :

1. NHGRI expands effort to revolutionize sequencing technologies
2. Detection of DNA on nanotubes offers new sensing, sequencing technologies
3. New GI technologies improve internal organ visualization
4. Plant-cell-produced technologies-cutting edge approach to bringing solutions to the market
5. Five new technologies that promise to transform medicine
6. Researchers develop technologies to devour food pathogens
7. Are genomic technologies the answer to world hunger?
8. Faster, low cost sequencing technologies needed to drive era of personalized medicine
9. New technologies coming too fast for Indian farmers
10. Ancient DNA confirms single origin of Malagasy primates
11. Updated data on novel HPV vaccine confirms efficacy in large population

Post Your Comments:
(Date:11/5/2009)... at Yale University have developed synthetic molec...se to HIV and HIV-infected cells, as well as to pr...ine in the Journal of the American Chemical Socie...r these diseases. , The molecules called "anti...d "antibody-recruiting molecule targeting prostate...
(Date:11/4/2009)...ral science) , United States Using Less Water ... than it did 35 years ago, despite a 30 percent po...y attributable to alternative cooling methods at p... According to the latest USGS water use report, ne...oes to cooling thermoelectric power plants. Irriga...
(Date:11/4/2009)...ria, it turns out, hold the power to help militari...orld clean up toxic waste on test sites. , Compo...nvented back in World War II and have been used in...y compounds are often used to propel tank shells a...But with increased knowledge of their environmenta...
Breaking Biology News(10 mins):New synthetic molecules trigger immune response to HIV and prostate cancer 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Genomic research will enable greener cleanup of military explosive test sites 2URL Pharma Acquires PharmPro Manufacturing Facility and Equipment 53460 1URL Pharma Acquires PharmPro Manufacturing Facility and Equipment 53460 2StayWell Custom Communications Partnership With HealthMedia 28R 29 Yields State Of The Art Online Health Platform 53458 1StayWell Custom Communications Partnership With HealthMedia 28R 29 Yields State Of The Art Online Health Platform 53458 2StayWell Custom Communications Partnership With HealthMedia 28R 29 Yields State Of The Art Online Health Platform 53458 3StayWell Custom Communications Partnership With HealthMedia 28R 29 Yields State Of The Art Online Health Platform 53458 4STAAR Surgical Generates Cash From Operations During Second Quarter 53456 1STAAR Surgical Generates Cash From Operations During Second Quarter 53456 2STAAR Surgical Generates Cash From Operations During Second Quarter 53456 3STAAR Surgical Generates Cash From Operations During Second Quarter 53456 4STAAR Surgical Generates Cash From Operations During Second Quarter 53456 5STAAR Surgical Generates Cash From Operations During Second Quarter 53456 6STAAR Surgical Generates Cash From Operations During Second Quarter 53456 7STAAR Surgical Generates Cash From Operations During Second Quarter 53456 8STAAR Surgical Generates Cash From Operations During Second Quarter 53456 9STAAR Surgical Generates Cash From Operations During Second Quarter 53456 10STAAR Surgical Generates Cash From Operations During Second Quarter 53456 11STAAR Surgical Generates Cash From Operations During Second Quarter 53456 12STAAR Surgical Generates Cash From Operations During Second Quarter 53456 13STAAR Surgical Generates Cash From Operations During Second Quarter 53456 14STAAR Surgical Generates Cash From Operations During Second Quarter 53456 15STAAR Surgical Generates Cash From Operations During Second Quarter 53456 16STAAR Surgical Generates Cash From Operations During Second Quarter 53456 17STAAR Surgical Generates Cash From Operations During Second Quarter 53456 18STAAR Surgical Generates Cash From Operations During Second Quarter 53456 19STAAR Surgical Generates Cash From Operations During Second Quarter 53456 20STAAR Surgical Generates Cash From Operations During Second Quarter 53456 21STAAR Surgical Generates Cash From Operations During Second Quarter 53456 22
...racked down the biological trigger that gives rise...bone disorder that can cause blindness and deafnes...ne regulation and could lead to new treatments for..., A research team from Lawrence Livermore and Lawr...Institutes for BioMedical Research in Switzerland,...
...the National Institute of Standards and Technology...te,s Early Detection Research Network (EDRN), has ...es that use mitochondrial DNA as an early indicato...suggest that a relatively simple diagnostic test u...tection of some solid tumors, including lung cance...
... tens of thousands of biologists around the globe ...ghtning-fast online algorithm called BLAST ?typica... of genetic code, to be matched against the billio...arities that can shed light on functional or evolu...AST to churn through and produce vast amounts of d...
Other Biology News:Researchers track down cause of a disfiguring bone disorder 2Researchers track down cause of a disfiguring bone disorder 3Drawing with DNA: 'Bioart' illuminates genomics 2Drawing with DNA: 'Bioart' illuminates genomics 3
(Date:11/9/2009)... -- BioMed Realty Trust, Inc. (NYSE: BMR ) announ...s from lenders to increase the borrowing capacity ...an aggregate of $665 million, with no other change...age effective interest rate of the unsecured line ...maturity date remains August 1, 2011, which may be...
(Date:11/9/2009)...harmaceutical giants use Datafarm for production o...rm’s announcement comes on the heels of last...e Health Canada stated that, effective immediately...ory submissions for New Drug Submission (NDS) appl... Marlborough, MA (PRWEB) Novemb...
(Date:11/7/2009)...- Research projects in the areas of mathematics an...im Kunisky of Livingston, NJ and the team of Benja...ved the highest honors at the Region Five Finals o...mp; Technology, the nation,s premier high school s...m/cgi-bin/prnh/20070904/SIEMENSLOGO ) ,, Toni...
(Date:11/6/2009)...ire/ -- EUCODIS Bioscience, a company,developing, ...for the,chemical industry announced today that it ...us, the leading biopharmaceutical company in Latin...ioscience exclusive access - for the search,of enz...ction of,psychrophilic bacteria strains and other ...
Breaking Biology Technology:BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million 2BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million 3Datafarm Responds to Health Canada's Announcement of Hybrid eCTD Submission Procedural Simplification 2Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 2Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 3Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 4Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 5Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 6EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2
... facility in the Dodge Industrial Park here is pro...care technology company. , ,The company, API Inc....l park to replace two offices that were in separat...ce in April. The new building gives the company, f...than twice the space available in its two previous...
Hammes Co. selects SiteStuff as procurement company
...llaborate with the Harvard Center for Neurodegene...aging system, the IN Cell Analyzer, to enhance res...odegenerative diseases like Parkinson,s and Alzhei..., ,In addition, the Harvard center and GE will wor... help speed disease analysis in the lab. , ,GE He...
Other Biology Technology:
Anti-MPM-2, phospho-Ser / Thr-Pro (Mitotic protein monoclonal #2) Antibody, Agarose Conjugated from Upstate
Goat Anti-TNFalpha-IP 2 (G-17) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Mouse Anti-Neuropilin-2 Monoclonal Antibody, Unconjugated, Clone 54 from BD Biosciences Pharmingen
cAMP Competitive immunoassay Assay Kit, HTRF from Cisbio
Biology Products: